Company intelligence / Profile preview

Ennature Biopharma

Kashipur, Uttarakhand, Indiaennaturebiopharma.com ↗

Ownership: Private
Development stage: Other

Overview

Ennature Biopharma has clinically validated branded nutraceutical ingredients such as Maxicuma®, Xanthogreen®, and Gingeren®. Clinical studies show Maxicuma® reduces joint pain/stiffness; Xanthogreen® improves eye health; Gingeren® supports general female health. These products use proprietary delivery technologies to enhance efficacy and absorption.

Therapeutic areas: OphthalmologyPsychiatryRheumatologyWomen's Health
Modalities: Small molecule (phytochemicals)Botanical extractNutraceutical ingredient
Industry: Food & Nutrition

Partnerships

Univar Solutions (North America distribution)

Beyond the preview

Go deeper on Ennature Biopharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ennature Biopharma.

Explore the full profile